Semaglutide effects on body and performance in athletes
Treatments studied
This study tests whether a short course of semaglutide (a medication used for diabetes and weight loss) changes body composition and exercise performance in healthy, experienced endurance athletes. It may help understand how this drug affects athletes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a triathlete or distance runner with at least 5 years of training and more than 10 hours of training per week.
- You are between 18 and 45 years old.
- Your body mass index (BMI) is between 21.0 and 26.0.
- You do not take any regular medications (occasional pain relievers or allergy meds are okay).
- You do not have chronic diseases like diabetes or eating disorders, and you have normal kidney function and heart rhythm.
- If you are female, you are not pregnant, you have not used hormonal contraceptives in the last 6 months, and you have regular menstrual cycles (21-35 days).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if semaglutide, a medication used for diabetes and weight loss, changes body composition (muscle vs. fat) and running performance in healthy, experienced runners. It may help understand how this drug affects athletes.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This study tests whether a weekly injection of semaglutide (a medication used for weight loss and diabetes) can help reduce symptoms of depression in people who have major depressive disorder and are overweight or obese.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
Hear when a new Body Composition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.